Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Alcidion Group Limited ( (AU:ALC) ) has shared an update.
Alcidion reported solid momentum in the December quarter of FY26, highlighted by its selection as preferred supplier for a major Electronic Patient Record contract with University Hospitals Sussex NHS Foundation Trust, expected to carry a total contract value of at least $35 million and become its largest UK engagement once executed. Quarterly new total contract value reached $15.4 million, driven largely by a $12.3 million expansion of its Miya Precision deployment with Leidos for the Commonwealth of Australia and several renewals, lifting FY26 contracted revenue to $43.1 million as at 31 December—40% higher than a year earlier and already exceeding FY25 full-year revenue. Despite an operating cash outflow of $1.9 million in Q2, the company ended the period with $14.2 million in cash, no debt, a sizeable debtor ledger and strong January collections, and it reaffirmed guidance for positive EBITDA and operating cash flow at least in line with FY25, underscoring improving scale, disciplined cost management and growing recurring revenue for stakeholders.
The most recent analyst rating on (AU:ALC) stock is a Buy with a A$0.13 price target. To see the full list of analyst forecasts on Alcidion Group Limited stock, see the AU:ALC Stock Forecast page.
More about Alcidion Group Limited
Alcidion Group Limited is an Australian-listed health technology company that provides clinical software solutions, including its Miya Precision platform and Electronic Patient Record (EPR) systems, to healthcare providers such as hospitals, health trusts and defence health services. The company focuses on improving healthcare delivery and operational efficiency across Australia and the UK, with a growing presence in large NHS trusts and specialised deployments like those supporting the Australian Defence Force.
Average Trading Volume: 1,016,927
Technical Sentiment Signal: Buy
Current Market Cap: A$154.4M
For a thorough assessment of ALC stock, go to TipRanks’ Stock Analysis page.